[Alpha1 antitrypsin]

Dahl R, Rasmussen SR
Record ID 32013000044
Original Title: Alfa-1 antitrypsin-mangel – en kommenteret udenlandsk medicinsk teknologivurdering
Authors' recommendations: There is no evidence that medical treatment of the rare disease alpha1-antitrypsin is better than the treatment patients receive today. This report is a review of a Canadian HTA commented by Danish experts.
Project Status: Completed
Year Published: 2008
English language abstract: There is no English language summary available
Publication Type: Not Assigned
Country: Denmark
MeSH Terms
  • alpha 1-Antitrypsin
  • alpha 1-Antitrypsin Deficiency
  • Serine Proteinase Inhibitors
  • Pulmonary Emphysema
Organisation Name: Danish Centre for Evaluation and Health Technology Assessment
Contact Address: National Board of Health, PO Box 1881, Islands Brygge 67, DK-2300 Copenhagen S, Denmark. Tel: 45 72 22 74 48; Fax: 45 72 22 74 07/67
Contact Name: dacehta@sst.dk
Contact Email: dacehta@sst.dk
Copyright: Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.